VRT is designed to strengthen the visual information processing of residual neuronal structures that have survived following acute lesions of the nervous system resulting from trauma, stroke, inflammation, or elective surgery for removal of brain tumors. By repeated activation through the course of the therapy, patients use the program to train and improve their impaired visual functions, and thus regain useful vision in the area of the visual field deficit.
VRT is performed on a computer at home twice daily, six days a week for six months. During each session, patients focus on a central point displayed on the screen and respond every time they see light stimuli appear elsewhere on the screen. The light stimuli are typically presented along the border of the intact and damaged visual field. The therapy is monitored and updated monthly by NovaVision Clinical Staff as therapy progresses and vision is improved.
NovaVision’s mission is to improve the vision of patients with neurological visual impairments and enhance the quality of life for our patients and their families; therefore we provide a portfolio of FDA registered therapy and diagnostic products for vision disorders resulting from a stroke or brain injury. Our therapies are evidence-based, supported by decades of scientific research and clinical studies.
Our headquarters are in Boca Raton, Florida and we have offices in Germany and the UK.